Cova322 (Anti-IL-17 & TNF-Alpha)

製品コード：A4043        

印刷

Cova322 is a bispecific FynomAb targeting TNF and IL-17A, created by fusing a small anti-IL-17A Fynomer to the anti-TNF antibody adalimumab. It shows potent inhibition of TNF and IL-17A in vitro and in vivo, offering potential benefits for inflammatory disease treatment. M.W 161.9 kDa.

製品説明

CAS No. N/A
Source CHO
Storage
(From the date of receipt)		 -80℃(avoid freeze-thaw cycles)
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。